R. Stadler, “Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial”, AO, vol. 45, no. 4, pp. 389–399, Jan. 2006.